1. Academic Validation
  2. AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking

AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking

  • Neoplasia. 2018 Oct;20(10):1008-1022. doi: 10.1016/j.neo.2018.08.005.
Selma Maacha 1 Jun Hong 1 Ariana von Lersner 2 Andries Zijlstra 2 Abbes Belkhiri 3
Affiliations

Affiliations

  • 1 Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • 2 Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37240, USA.
  • 3 Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: abbes.belkhiri@vanderbilt.edu.
Abstract

Esophageal adenocarcinoma (EAC) is a highly aggressive malignancy that is characterized by resistance to chemotherapy and a poor clinical outcome. The overexpression of the receptor tyrosine kinase AXL is frequently associated with unfavorable prognosis in EAC. Although it is well documented that AXL mediates Cancer cell invasion as a downstream effector of epithelial-to-mesenchymal transition, the precise molecular mechanism underlying this process is not completely understood. Herein, we demonstrate for the first time that AXL mediates cell invasion through the regulation of lysosomes peripheral distribution and Cathepsin B secretion in EAC cell lines. Furthermore, we show that AXL-dependent peripheral distribution of lysosomes and cell invasion are mediated by extracellular acidification, which is potentiated by AXL-induced secretion of lactate through AKT-NF-κB-dependent MCT-1 regulation. Our novel mechanistic findings support future clinical studies to evaluate the therapeutic potential of the Axl Inhibitor R428 (BGB324) in highly invasive EAC.

Figures
Products